Exact Mass: 466.0533

Exact Mass Matches: 466.0533

Found 74 metabolites which its exact mass value is equals to given mass value 466.0533, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Adenylylanthranilate

N-Adenylylanthranilate

C17H19N6O8P (466.1002)


   

6-Chloro-5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)indoline-1-carboxamide dihydrochloride

6-Chloro-5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)indoline-1-carboxamide dihydrochloride

C21H21Cl3N4O2 (466.073)


SB 242084 dihydrochloride is a selective, competitive and high-affinity (pKi=9.0) 5-HT2C receptor antagonist (crosses the blood-brain barrier). SB 242084 dihydrochloride increases basal activity of dopaminergic neurons in the ventral tegmental area (VTA) of the midbrain and dopamine release in the vomeronasal nucleus. SB 242084 dihydrochloride also increases mitochondrial gene expression and oxidative metabolism via 5-HT2A receptor. SB 242084 dihydrochloride has good research potential in the negative symptoms of anxiety, depression and schizophrenia, as well as in acute organ damage[1][2][3].

   

BL IV

3,4-Bis(acetyloxy)-11,12-dihydroxy-5-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2,4,6,10,12-hexaen-6-yl acetic acid

C24H18O10 (466.09)


BL IV is found in mushrooms. BL IV is a constituent of the kurukawa mushroom (Boletopsis leucomelas) (edibility not reported)

   

carlliiionaln

2-({[({2-[(C-hydroxycarbonimidoyloxy)methyl]-4-oxo-1-sulphoazetidin-3-yl}carbamoyl)(2-imino-2,3-dihydro-1,3-thiazol-4-yl)methylidene]amino}oxy)acetic acid

C12H14N6O10S2 (466.0213)


   

(4-Chlorophenyl) (1R)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

6-Chloro-1,3,4,9-tetrahydro-1-(4-methoxyphenyl)-, 4-chlorophenyl ester, (1S)-2H-pyrido(3,4-b)indole-2-carboxylic acid

C25H20Cl2N2O3 (466.0851)


   

2-(alpha-hydroxyethyl)thiamine diphosphate

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(1-hydroxyethyl)-4-methyl-5-(2-{[(phosphonatooxy)phosphinato]oxy}ethyl)-1,3-thiazol-3-ium

C14H20N4O8P2S (466.0477)


2-(alpha-hydroxyethyl)thiamine diphosphate, also known as 2-(α-hydroxyethyl)-tpp, is a member of the class of compounds known as thiamine phosphates. Thiamine phosphates are thiamine derivatives in which the hydroxyl group of the ethanol moiety is substituted by a phosphate group. 2-(alpha-hydroxyethyl)thiamine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2-(alpha-hydroxyethyl)thiamine diphosphate can be found in a number of food items such as amaranth, wild rice, date, and elliotts blueberry, which makes 2-(alpha-hydroxyethyl)thiamine diphosphate a potential biomarker for the consumption of these food products. 2-(α-hydroxyethyl)thiamine diphosphate, also known as 2-(α-hydroxyethyl)-tpp, is a member of the class of compounds known as thiamine phosphates. Thiamine phosphates are thiamine derivatives in which the hydroxyl group of the ethanol moiety is substituted by a phosphate group. 2-(α-hydroxyethyl)thiamine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2-(α-hydroxyethyl)thiamine diphosphate can be found in a number of food items such as amaranth, wild rice, date, and elliotts blueberry, which makes 2-(α-hydroxyethyl)thiamine diphosphate a potential biomarker for the consumption of these food products.

   

EP_M467

EP_M467

C20H20ClFN4O4S (466.0878)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2204

   
   

4-O-galloylbergenin|4-O-Galloylnorbergenin

4-O-galloylbergenin|4-O-Galloylnorbergenin

C20H18O13 (466.0747)


   

Deacetylkirschsteinin

Deacetylkirschsteinin

C24H18O10 (466.09)


   

1-glycerophophoryl-2-hydroxy-3-<5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy>propane|1-glycerophophoryl-2-hydroxy-3-[5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy]propane

1-glycerophophoryl-2-hydroxy-3-<5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy>propane|1-glycerophophoryl-2-hydroxy-3-[5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy]propane

C13H28AsO11P (466.0585)


   

11-O-galloylbergenin|11-O-Galloylnorbergenin|6-O-galloylnorbergenin

11-O-galloylbergenin|11-O-Galloylnorbergenin|6-O-galloylnorbergenin

C20H18O13 (466.0747)


   

eriocephaloside

eriocephaloside

C24H18O10 (466.09)


   
   

Cys Asp Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C15H22N4O11S (466.1006)


   

Asp Asp Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C15H22N4O11S (466.1006)


   
   

Ziprasidone Hydrochloride Monohydrate

Ziprasidone Hydrochloride Monohydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].

   

4-oxopent-2-en-2-olate,thulium(3+)

4-oxopent-2-en-2-olate,thulium(3+)

C15H21O6Tm (466.068)


   

Varlitinib

Varlitinib

C22H19ClN6O2S (466.0979)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   
   

THYMIDINE 5-MONOPHOSPHATE P-NITROPHENYL ESTER SODIUM SALT

THYMIDINE 5-MONOPHOSPHATE P-NITROPHENYL ESTER SODIUM SALT

C16H18N3NaO10P (466.0627)


   

MK-8245

MK-8245

C17H16BrFN6O4 (466.04)


MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, with IC50s of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with antidiabetic and antidyslipidemic efficacy[1].

   

Benzothiazolium,3-ethyl-2-[(3-ethyl-2(3H)-benzothiazolylidene)methyl]-, iodide (1:1)

Benzothiazolium,3-ethyl-2-[(3-ethyl-2(3H)-benzothiazolylidene)methyl]-, iodide (1:1)

C19H19IN2S2 (466.0034)


   
   

Carumonam

(Z)-Carumonam

C12H14N6O10S2 (466.0213)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DF - Monobactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic An N-sulfonated monobactam antibiotic.

   

2-hydroxy-1,3-propylenediamine-N,N,N,N-tetra(methylenephosphonic acid)

2-hydroxy-1,3-propylenediamine-N,N,N,N-tetra(methylenephosphonic acid)

C7H22N2O13P4 (466.0072)


   

5-[(2R)-2-([(2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO)PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE DISODIUM

5-[(2R)-2-([(2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO)PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE DISODIUM

C20H19ClNNa2O7 (466.0645)


   

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxy-5-(methylamino)phenyl]acetamide

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxy-5-(methylamino)phenyl]acetamide

C16H15BrN6O6 (466.0236)


   

Tetraphenylphosphonium iodide

Tetraphenylphosphonium iodide

C24H20IP (466.0347)


   

5-(2-Bromophenyl)-1-trityl-1H-tetrazole

5-(2-Bromophenyl)-1-trityl-1H-tetrazole

C26H19BrN4 (466.0793)


   

tris[4-(trifluoromethyl)phenyl]phosphane

tris[4-(trifluoromethyl)phenyl]phosphane

C21H12F9P (466.0533)


   

bis(2,4,6-trimethylpyridine)bromonium hexafluorophosphate

bis(2,4,6-trimethylpyridine)bromonium hexafluorophosphate

C16H22BrF6N2P (466.0608)


   

[[(3,5-Dimethyl-4-sulfo-1H-pyrrol-2-yl)(3,5-dimethyl-4-sulfo-2H-pyrrol-2-ylidene)methyl]methane](difluoroborane) Disodium Salt

[[(3,5-Dimethyl-4-sulfo-1H-pyrrol-2-yl)(3,5-dimethyl-4-sulfo-2H-pyrrol-2-ylidene)methyl]methane](difluoroborane) Disodium Salt

C14H15BF2N2Na2O6S2 (466.0228)


   

Nickel iodate tetrahydrate

Nickel iodate tetrahydrate

Ni(IO3)2•4H2O (466.0373)


   

ethyl 6-broMo-2-(((4-fluorophenylthio)MethylaMino)Methyl)-5-hydroxy-1-Methyl-1H-indole-3-carboxylate

ethyl 6-broMo-2-(((4-fluorophenylthio)MethylaMino)Methyl)-5-hydroxy-1-Methyl-1H-indole-3-carboxylate

C20H20BrFN2O3S (466.0362)


   

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid

C21H23ClN2O6S (466.0965)


   

sodium 4-chloro-3-[[4-[(4-ethoxyphenyl)azo]phenyl]azo]benzenesulphonate

sodium 4-chloro-3-[[4-[(4-ethoxyphenyl)azo]phenyl]azo]benzenesulphonate

C20H16ClN4NaO4S (466.0478)


   

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate

C25H20Cl2N2O3 (466.0851)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor

   

4-[3-(5-bromo-2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrol-2-yl]pyridine

4-[3-(5-bromo-2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrol-2-yl]pyridine

C24H20BrClN2O (466.0447)


   

N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide

N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide

C22H18N4O2S3 (466.0592)


   

7-Anilino-3-(4-bromophenyl)-5-morpholino-1,4-thiazepine-6-carbonitrile

7-Anilino-3-(4-bromophenyl)-5-morpholino-1,4-thiazepine-6-carbonitrile

C22H19BrN4OS (466.0463)


   
   

7-(1,1-Dioxo-1H-benzo[D]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-C]pyran-3-carboxylic acid

7-(1,1-Dioxo-1H-benzo[D]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-C]pyran-3-carboxylic acid

C18H14N2O9S2 (466.0141)


   

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine

C20H20ClFN4O4S (466.0878)


   

2-hydroxybenzoyl-AMP(1-)

2-hydroxybenzoyl-AMP(1-)

C17H17N5O9P- (466.0764)


   

4-hydroxybenzoyl-AMP(1-)

4-hydroxybenzoyl-AMP(1-)

C17H17N5O9P- (466.0764)


   

2-(1-Hydroxyethyl)thiamine diphosphate(2-)

2-(1-Hydroxyethyl)thiamine diphosphate(2-)

C14H20N4O8P2S-2 (466.0477)


   

N-adenylylanthranilic acid

N-adenylylanthranilic acid

C17H19N6O8P (466.1002)


   
   

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate

C21H24Cl2N4O2S (466.0997)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   
   

4-(Difluoromethoxy)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-(Difluoromethoxy)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C24H16F2N2O4S (466.0799)


   

N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide

N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide

C21H17ClF2N2O4S (466.0566)


   

5-O-[(S)-[(2-Aminobenzoyl)oxy](Hydroxy)phosphoryl]adenosine

5-O-[(S)-[(2-Aminobenzoyl)oxy](Hydroxy)phosphoryl]adenosine

C17H19N6O8P (466.1002)


   

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide

C23H19ClN4O3S (466.0866)


   

1,3-Diphenyl-4-pyrazolecarboxylic acid [2-[(3,5-dichloro-2-pyridinyl)amino]-2-oxoethyl] ester

1,3-Diphenyl-4-pyrazolecarboxylic acid [2-[(3,5-dichloro-2-pyridinyl)amino]-2-oxoethyl] ester

C23H16Cl2N4O3 (466.0599)


   

3-hydroxybenzoyl-AMP

3-hydroxybenzoyl-AMP

C17H17N5O9P- (466.0764)


   

4-[4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

4-[4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

C24H22N2O4S2 (466.1021)


   

[2-(5,7-Dihydroxy-4-oxo-2-phenylchromen-8-yl)-4,5-dihydroxyoxan-3-yl] hydrogen sulate

[2-(5,7-Dihydroxy-4-oxo-2-phenylchromen-8-yl)-4,5-dihydroxyoxan-3-yl] hydrogen sulate

C20H18O11S (466.057)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-aminobenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-aminobenzoate

C17H19N6O8P (466.1002)


   

6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride

6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride

C21H21Cl3N4O2 (466.073)


   

2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropyl)phosphinic acid

2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropyl)phosphinic acid

C13H28AsO11P (466.0585)


   

[(2s,4r,5s,6s,7r)-5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl]methyl 3,4,5-trihydroxybenzoate

[(2s,4r,5s,6s,7r)-5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl]methyl 3,4,5-trihydroxybenzoate

C20H18O13 (466.0747)


   

(2s,4r,5r,6s,7s)-5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-6-yl 3,4,5-trihydroxybenzoate

(2s,4r,5r,6s,7s)-5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-6-yl 3,4,5-trihydroxybenzoate

C20H18O13 (466.0747)


   

5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-6-yl 3,4,5-trihydroxybenzoate

5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-6-yl 3,4,5-trihydroxybenzoate

C20H18O13 (466.0747)


   

{5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl}methyl 3,4,5-trihydroxybenzoate

{5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl}methyl 3,4,5-trihydroxybenzoate

C20H18O13 (466.0747)


   

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate

C24H18O10 (466.09)


   

(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropyl)phosphinic acid

(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropyl)phosphinic acid

C13H28AsO11P (466.0585)


   

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)


   

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

17-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-4,12,20-trioxapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁴,¹⁹]henicosa-1(13),2(11),3(8),6,9,14(19),15,17-octaene-5,21-dione

C24H18O10 (466.09)


   

[(2s,4r,5r,6s,7r)-5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl]methyl 3,4,5-trihydroxybenzoate

[(2s,4r,5r,6s,7r)-5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl]methyl 3,4,5-trihydroxybenzoate

C20H18O13 (466.0747)